Sun Pharma Advanced Research Company informs about resignation of independent director

02 Mar 2020 Evaluate

Pursuant  to Regulation  30  of  the  SEBI  (Listing  Obligation  &  Disclosure  Requirements) Regulations,  2015,  Sun Pharma Advanced Research Company has informed that  the  Company  has  received a letter  from Mark Simon, tendering his resignation as an Independent Director of the Company (copy enclosed). In his letter, Simon has conveyed that he intends to pursue an employment opportunity which  might  constrain  his  ability  to  function  as  an  Independent  Director  of  the Company. Further, Simon has stated that he tenders his resignation as an Independent Director on the Board of the Company and all the Committees there under in which he is a member, with immediate effect. Further,  in  compliance  with clause 7B  (ii) of Part  A of  Schedule  B  of  the SEBI  (LODR) Regulations,  Simon  has  confirmed  that  that there is no  material  reason  other  than mentioned above for his resignation. The Chairman and Managing Director of the Company has accepted Simon’s resignation and has placed on record the appreciation for the valuable contributions by Simon during his association with the Company. The Board would appoint a suitable replacement in place of Simon within the time stipulated under the applicable laws/regulations.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

134.45 0.70 (0.52%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 643.75
Indegene 519.25
CMS Info Systems 339.55
Sagility 52.19
Smartworks Coworking 476.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×